119th Congress · introduced in the Senate · Jan 28, 2025
Protect Infant Formula from Contamination Act
Official title from Congress.gov
Latest action (May 4, 2026): Held at the desk.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in Senate (Jan 28, 2025)
Protect Infant Formula from Contamination Act
This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula.
Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded.
Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day.
Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action.
Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Held at the desk.
Received in the House.
Message on Senate action sent to the House.
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S2074-2075; text: CR S2074)
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 306.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
Child health · Congressional oversight · Consumer affairs · Food supply, safety, and labeling · Government information and archives · Manufacturing · Nutrition and diet · Supply chain
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
16 citations.
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…9257/S. 4754, Primary and Behavioral Health Care Access Act H.R. 9393, Lower Costs, More Transparency Act of 2026 H.R. 10280, 9-8-8 Implementation Act of 2026 S. 272, Protect Infant Formula from Contamination Act S. 278, Kids Off Social Media Act S. 705, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 9, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…ing maternal and infant health and paid leave (H.R.5390/S.2823, FAMILY Act), improving affordable access to formula, improving nutrition standards for infants (S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act), covering formula for women medically unable to breastfeed (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · amended · posted Sep 22, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…ding maternal health issues, improving affordable access to formula, improving nutrition standards for infants (Protect Infant Formula from Contamination Act - S.272), and growing manufacturing opportunities for small domestic infant formula producers.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · amended · posted Sep 22, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
….R.5390/S.2823, FAMILY Act), improving affordable access to formula, improving nutrition standards for infants (Protect Infant Formula from Contamination Act - S.272), and growing manufacturing opportunities for small domestic infant formula producers.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · amended · posted Sep 22, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…nal health issues (H.R.7973, Momnibus Act; H.R.5390/S.2823, FAMILY Act), improving affordable access to formula, and improving nutrition standards for infants (S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · amended · posted Sep 22, 2026 · issue area: Agriculture
$50,000
Paid to lobbying firm
Advocate for issues related to infant formula, including improving access and nutrition standards for infants; H.R.7973, Momnibus Act, S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 22, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…rency Act of 2026 S. 222/H.R. 649, Whole Milk for Healthy Kids Act of 2025 S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 272, Protect Infant Formula from Contamination Act S. 278, Kids Off Social Media Act S. 705, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FOOD MARKETPLACE INC · lobbying firm or registrant: FOOD MARKETPLACE INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Food Industry (safety, labeling, etc.)
$584,000
Spent on own lobbying
…modernization SNAP error rate H.R. 4158 - Ensuring Fee-Free Benefit Transactions Act H.R. 4692 - MAMDANI Act S. 3934/H.R. 6199 - Medical Nutrition Therapy Act S.272 - Protect Infant Formula from Contamination Act H.R. 7567 - Farm, Food, and National Security Act of 2026 H.R. 7469 - SNAP Online Access Act Agriculture Act of…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Agriculture
$50,000
Paid to lobbying firm
Advocate for issues related to infant formula, including improving access and nutrition standards for infants; H.R.7973, Momnibus Act, S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…o infant formula, including maternal health issues (H.R.7973, Momnibus Act), improving affordable access to formula, improving nutrition standards for infants (S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act), and covering formula for women medically unable to breastfe…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 24, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…tal Workforce Act S. 222/H.R. 649, Whole Milk for Healthy Kids Act of 2025 S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 272, Protect Infant Formula from Contamination Act S. 278, Kids Off Social Media Act S. 705, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FOOD MARKETPLACE INC · lobbying firm or registrant: FOOD MARKETPLACE INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Food Industry (safety, labeling, etc.)
$670,000
Spent on own lobbying
…modernization SNAP error rate H.R. 4158 - Ensuring Fee-Free Benefit Transactions Act H.R. 4692 - MAMDANI Act S. 3934/H.R. 6199 - Medical Nutrition Therapy Act S.272 - Protect Infant Formula from Contamination Act H.R. 7567 - Farm, Food, and National Security Act of 2026 H.R. 7469 - SNAP Online Access Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION) · lobbying firm or registrant: CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · amended · posted Jan 7, 2026 · issue area: Food Industry (safety, labeling, etc.)
$715,000
Spent on own lobbying
…and Childhood Diabetes Reduction Act. Issues relating to infant and toddler foods- H.R. 2472 Improving Newborns Food and Nutrition Testing Safety Act of 2025; S. 272 Protect Infant Formula from Contamination Act. Issues relating to GRAS (Generally Recognized as Safe) and pre-market chemical regulations.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION) · lobbying firm or registrant: CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · amended · posted Jan 7, 2026 · issue area: Food Industry (safety, labeling, etc.)
$1,421,000
Spent on own lobbying
…and Childhood Diabetes Reduction Act. Issues relating to infant and toddler foods- H.R. 2472 Improving Newborns Food and Nutrition Testing Safety Act of 2025; S. 272 Protect Infant Formula from Contamination Act. Issues relating to GRAS (Generally Recognized as Safe) and pre-market chemical regulations.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 19, 2025 · issue area: Health Issues
$50,000
Paid to lobbying firm
…ding maternal health issues, improving affordable access to formula, improving nutrition standards for infants (Protect Infant Formula from Contamination Act - S.272), and growing manufacturing opportunities for small domestic infant formula producers.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Health Issues
$50,000
Paid to lobbying firm
…ding maternal health issues, improving affordable access to formula, improving nutrition standards for infants (Protect Infant Formula from Contamination Act - S.272), and growing manufacturing opportunities for small domestic infant formula producers.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing